Form 4: Integra Lifesciences Director Buys 9,000 Shares

Jeffrey A. Graves, a director at Integra Lifesciences Holdings Corp., purchased 9,000 shares of common stock for $11.35 per share.

Summary

• Jeffrey A. Graves, a Director of Integra Lifesciences Holdings Corp. (IART), acquired 9,000 shares of common stock.
• The transaction occurred on November 5, 2025.
• Shares were purchased at a price of $11.35 per share.
• Following this transaction, Mr. Graves beneficially owns 41,086 shares of Integra Lifesciences common stock directly.
• The transaction was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 8

Explanation: The direct purchase of a significant number of shares by a company director is a strong positive signal, indicating confidence in the company's future performance and valuation.

Positives

• A director's purchase of company stock signals confidence in the company's future prospects and valuation.
• The acquisition of 9,000 shares at $11.35 per share represents a direct investment by a key insider.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's future performance.

Industry Context

Insider buying, particularly by a director, is often interpreted by the market as a positive signal, suggesting that those closest to the company believe the stock is undervalued or expect positive developments. This can sometimes precede periods of outperformance relative to peers, though it is not a guarantee.

Related Party Transactions

• Jeffrey A. Graves, a director of Integra Lifesciences Holdings Corp., purchased 9,000 shares of the company's common stock, which constitutes a related party transaction.

Stakeholder Impact

• Shareholders may view the director's purchase as a positive indicator of the company's intrinsic value and future growth potential, potentially increasing investor confidence.
• Employees and other stakeholders might interpret this as a sign of stability and positive internal outlook.

Key Dates

Recommendation

The direct purchase of 9,000 shares by a company director, Jeffrey A. Graves, signals strong insider confidence in Integra Lifesciences Holdings Corp.'s future. Such insider buying often suggests that the stock is undervalued or that positive developments are anticipated, making it a compelling 'buy' signal for investors.

Keywords

Integra Lifesciences, IART, Insider Purchase, Director Stock Buy, Form 4, Jeffrey A Graves, Equity Acquisition, Rule 10b5-1